Biomarkers in Colorectal Cancer: Actual and Future Perspectives
International Journal of Molecular Sciences · 27.10.2024 · 25 (21) · 11535
DOI: 10.3390/ijms252111535 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.10.2024. Verfasst von Horia-Dan Lișcu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Oncological Radiotherapy and Medical Imaging, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Biomarkers in colorectal cancer (CRC) are of great interest in the current literature due to improvements in techniques such as liquid biopsy and next-generation sequencing (NGS). However, screening methods vary globally, with multi-target stool DNA (mt-sDNA) predominantly used in the USA and, more recently, the Cologuard Plus; biomarkers such as the Galectins family and septins show promise in early detection. Gut microbiome assessments, such as Fusobacterium nucleatum, are under intense exploration. Diagnostic tests, such as circulating DNA analysis via NGS, exhibit effectiveness and are being increasingly adopted. Circulating tumor cells emerge as potential alternatives to traditional methods in terms of diagnosis and prognosis. Predictive biomarkers are well established in guidelines; nonetheless, with the aid of machine learning and artificial intelligence, these biomarkers may be improved. This review critically explores the actual dynamic landscape of CRC biomarkers and future, promising biomarkers involved in screening, diagnosis, and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Oncological Radiotherapy and Medical Imaging, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Radiotherapy Department, Colțea Clinical Hospital, 030167 Bucharest, Romania.
- Department of Surgery, Bagdasar Arseni Clinical Emergency Hospital, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Bd., 050474 Bucharest, Romania.
- Department of Pathology, University Emergency Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Bd., 050474 Bucharest, Romania.
- Department of Pathology, Institute of Oncology Alexandru Trestioreanu, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Department of Gastroenterology, Floreasca Emergency Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
ORCID-Profile: Horia-Dan Lișcu, Nicolae Verga, Dimitrie-Ionuț Atasiei, Adrian Vasile Dumitru, Andreea-Iuliana Ionescu
Zitieren
APA
Lișcu, H. D., Verga, N., Atasiei, D. I., Badiu, D. C., Dumitru, A. V., Ultimescu, F., Pavel, C., Stefan, R. E., Manole, D. C., & Ionescu, A. I. (2024). Biomarkers in Colorectal Cancer: Actual and Future Perspectives. International Journal of Molecular Sciences, 25(21), 11535. https://doi.org/10.3390/ijms252111535
Vancouver
Lișcu HD, Verga N, Atasiei DI, Badiu DC, Dumitru AV, Ultimescu F, et al. Biomarkers in Colorectal Cancer: Actual and Future Perspectives. International Journal of Molecular Sciences. 2024;25(21):11535. doi:10.3390/ijms252111535
BibTeX
@article{Licu2024,
author = {Lișcu, Horia-Dan and Verga, Nicolae and Atasiei, Dimitrie-Ionuț and Badiu, Dumitru-Cristinel and Dumitru, Adrian Vasile and Ultimescu, Flavia and Pavel, Christopher and Stefan, Roxana-Elena and Manole, Diandra-Carmen and Ionescu, Andreea-Iuliana},
title = {Biomarkers in Colorectal Cancer: Actual and Future Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {21},
pages = {11535},
doi = {10.3390/ijms252111535}
}
EUVIMED